Clover Health Investments (CLOV) Operating Expenses (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Operating Expenses data on file, last reported at $721.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 55.7% year-over-year to $721.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (up 50.12% YoY), and the FY2025 full-year result was $2.0 billion, up 41.85% from the prior year.
• Operating Expenses for Q1 2026 stood at $721.9 million, up from $537.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $961.9 million in Q1 2022 and bottomed at -$1.5 billion in Q4 2022.
• The 5-year median for Operating Expenses is $401.7 million (2023), against an average of $411.6 million.
• Peak annual rise in Operating Expenses reached 201.13% in 2022, while the deepest fall reached 335.77% in 2022.
• A 5-year view of Operating Expenses shows it stood at -$1.5 billion in 2022, then surged by 125.74% to $375.5 million in 2023, then retreated by 4.56% to $358.4 million in 2024, then surged by 49.84% to $537.0 million in 2025, then soared by 34.42% to $721.9 million in 2026.
• The last three Operating Expenses figures came in at $721.9 million (Q1 2026), $537.0 million (Q4 2025), and $521.0 million (Q3 2025), per Business Quant data.

Peer Comparison